Uncategorised - European Medical Journal

EMJ Neurology 9.1 2021 Feature Image

Long-term Safety Outcomes with Inebilizumab Treatment in Neuromyelitis Optica Spectrum Disorder: The N-MOmentum Trial

Neuromyelitis optica spectrum disorder (NMOSD) is a severe autoimmune disease characterised by recurrent inflammation of the optic nerve…

EMJ Neurology 9.1 2021 Feature Image

Turner Syndrome and Craniosynostosis: An Unusual Combination

Turner syndrome (TS) is one of the most frequent chromosomal aberrations, caused by the partial or complete loss of one X chromosome…

EMJ Neurology 9.1 2021 Feature Image

Resting State Functional Connectivity Changes of the Pons in Patients with Migraine: A Cross-Sectional and Longitudinal Study

Previous studies support a pivotal role of the pons during the pain phase of a migraine attack.1-3 An altered activation of the pons during…

EMJ Neurology 9.1 2021 Feature Image

A Case of Subacute Combined Degeneration as a Manifestation of Pernicious Anaemia

The patient was admitted to the hospital for further study of the neurological changes, treatment of serious anaemia…

EMJ Neurology 9.1 2021 Feature Image

Successful Management of Parsonage–Turner Syndrome with Steroids in the Post-acute Weakness Phase: A Case Report

Parsonage–Turner Syndrome (PTS) is a rare disease of the brachial plexus of unclear aetiology. The authors present a case of PTS with a rare combination of unilateral brachial plexus, phrenic nerve, and recurrent laryngeal nerve injuries.

EMJ Neurology 9.1 2021 Feature Image

The Effects of Great Occipital Nerve Block Over Photophobia in Patients with Migraine

Photophobia is a sensory disturbance provoked by light commonly seen in several headache disorders. Photophobia affects as much…

Treating Ankylosing Spondylitis Using Engineered JAK Inhibitor: Upadacitinib

Researchers explored the efficacy of upadacitinib in treating AS. Upadacitinib targets the inflammatory pathway and works by inhibiting JAK, reducing the ability of JAK to cause inflammation in the joints.

Effective Novel Drug for Axial Psoriatic Arthritis

Phase III clinical trials analysed the efficaPhase III clinical trials analysed the efficacy of a novel antibody, guselkumab, for psoriatic arthritis with axial symptoms.

Two Pilots Walk into a Pharmacy

We discuss the role of pharmacists on hospital wards, explore microbial stewardship, consider the evidence behind aspirin as a prevention tool.

Webinar: Acute MSK pain: how to manage symptoms and stress

Musculoskeletal (MSK) pain and soft tissue injuries are very common both in sportspeople and in the general population and include different forms of traumas that must be properly treated to allow the return to normal life or sports activities.